Mice Model Market Analysis

Mice Model Market Analysis

In terms of mice, the inbred mice model market will reach over USD 4.5 billion by 2032. The growing adoption of inbred mice for studying the genetic bases of phenotypic variation and the rising use in cancer research for understanding the genetic basis of tumor development and cancer progression is bolstering segment development. For instance, inbred mice are commonly used to reproduce DIO models to reduce modeling time and attain stable metrics.
 

The mice model market revenue size from the CRISPR technology segment will reach more than USD 6 billion by the end of 2032. This is attributed to its cost-effectiveness, time efficiency, and convenience compared to traditional gene editing techniques such as transcription activators-like effective nucleases (TALENS). Moreover, growing awareness regarding the advantages of CRISPR technology is promoting product demand. A 2022 study highlighted that 54 of 85 isolates of enterococci species indicated a presence of CRISPR-Cas loci, accounting for more than 63% of total samples.

Regionally, North America accounted for over 80% of the mice model market revenue in 2022, attributed to the high prevalence of chronic diseases including diabetes and viral diseases. As per a recent report, by 2060, people under age 20 with type 2 diabetes would increase by approximately 675% in the U.S. Moreover, several research organizations in the region are also focusing on developing effective therapeutic drugs for the treatment of viral diseases, which is increasing the demand for mice models.